Nepal’s Rupani Rural Municipality conducted an innovative oral cholera vaccination (OCV) campaign in May in which vaccine recipients self-administered their second doses as part of a feasibility study. Aiming to reach 28,000 people in the country’s southeastern region, the effort was led by the nonprofit International Vaccine Institute (IVI) and partners, who provided the first dose of Euvichol-Plus (the OCV developed by IVI). IVI
Menu